XLV - Health Care Select Sector SPDR ETF
94.42 -0.04 (-0.04%)
After hours: 4:45PM EDT
| Previous Close | 94.27 |
| Open | 94.21 |
| Bid | 0.00 x 4000 |
| Ask | 0.00 x 2900 |
| Day's Range | 94.07 - 94.65 |
| 52 Week Range | 78.74 - 94.65 |
| Volume | 5,392,620 |
| Avg. Volume | 6,275,153 |
| Net Assets | 18.31B |
| NAV | 92.78 |
| PE Ratio (TTM) | N/A |
| Yield | 1.35% |
| YTD Return | 13.03% |
| Beta (3y) | 0.98 |
| Expense Ratio (net) | 0.14% |
| Inception Date | 1998-12-16 |
Yahoo Finance Video•10 hours agoMARKETS: What traders are watching today, as energy screams higher
Live from the floor of the New York Stock Exchange, Yahoo Finance's Jared Blikre joins Alexis Christoforous to break down the latest market moves.
- Yahoo Finance Video•10 days ago
As trade tensions rise, there are other headwinds threatening economy too
Yahoo Finance's Seana Smith and Dion Rabouin talk to Ron Weiner of RDM Financial Group about the biggest threats to the U.S. economy and where investors can find deals.
Yahoo Finance Video•13 days agoWhy states are more prepared for the next recession
While some sectors, like housing, is still recovering from the financial crisis, many state governments have built up rainy day funds and are better prepared to weather the next recession. Yahoo Finance’s Seana Smith, Maylan Studart, Rick Newman and Dion Rabouin discuss.
Market Realist•6 hours agoWhy JNJ Stock Rose ~2.4% Last Week
On September 21, Johnson & Johnson (JNJ) stock closed at $142.88, ~0.63% higher than the previous day’s closing price of $141.98. JNJ stock returned ~2.4% last week and is currently trading above its 50-day and 200-day moving averages of $135.35 and $128.52, respectively.
Market Realist•4 days agoWhy Merck Stock Has Risen 28.2% Year-to-Date
Merck (MRK) stock has risen from $54.93 on January 2 to $70.42 on September 18—a 28.2% increase year-to-date. The performance of Merck stock has been closely related to the sales, clinical trial outcomes, and regulatory decisions for the company’s leading immuno-oncology drug, Keytruda. Approved in 13 indications and eight tumor types, Keytruda reported sales of $1.7 billion in the second quarter.
Market Realist•4 days agoABT Returns Almost Double the S&P 500’s Year-to-Date Gain
As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date). In the same period, the S&P 500 has risen ~8%. Abbott Laboratories has clearly surpassed the market’s returns so far in 2018.
- MarketWatch•6 days ago
Health care ETF surges toward record in a broad sector rally
The SPDR Health Care Select Sector ETF rose 0.7% toward a record high in afternoon trade Tuesday, with 55 of its 63 equity components gaining ground. Among the ETF's (XLV) members which are also Dow Jones Industrial Average components, Pfizer Inc.'s stock shot up 1.5%, putting it on track to close at the highest level since December 2001. Also, shares of Johnson & Johnson gained 0.6% toward an eight-month high, Merck & Co. Inc. tacked on 0.4% to sit just shy of its 17-year high reached last Thursday, and UnitedHealth Group Inc. slipped 0.1% and was 2.2% below its Sept. 6 record close of $269.65. The XLV's biggest gainer was Abiomed Inc.'s stock , which rallied 2.7%, while its biggest decliner was AbbVie Inc.'s stock , which shed 2.1% after California sued the company alleging the payment of illegal kickbacks. The XLV has rallied 11% over the past three months, while the Dow has tacked on 5.2%.
- Investopedia•8 days ago
Top 3 Healthcare Stocks for 2018
The healthcare industry is watching the Trump presidency closely. President Trump's promise to repeal and replace Obamacare hit repeated stumbling blocks in Congress. Despite the uncertainty surrounding these efforts to overhaul the nation's healthcare system, a number of healthcare stocks rose dramatically throughout 2017.
Market Realist•11 days agoWhy Is BSX Stock Trading at Its 14-Year High Today?
Currently, BSX stock is trading near its all-time high. Boston Scientific (BSX) stock has been on a bullish trend over the last year, driven by strong fundamentals, a robust acquisition strategy, and a diverse product pipeline. Why did BSX stock jump today?
Market Realist•12 days agoJNJ Stock Up 7% in the Past Month: What Drove the Bulls?
On September 12, Johnson & Johnson (JNJ) stock closed at $139.36. That was a 0.61% rise from the previous day’s closing price of $138.51. Currently, JNJ stock is trading above its 50-day moving average of $133.29 and below its 200-day moving average of $127.99.
- Market Realist•14 days ago
Eli Lilly Initiates New Trial for Taltz in Plaque Psoriasis
Eli Lilly (LLY) announced in a press release on September 10 that the company has initiated the IXORA-R head-to-head (or H2H) study evaluating the superiority of drugs Taltz (ixekizumab) and Tremfya (guselkumab) in patients with moderate-to-severe plaque psoriasis. The below chart shows key highlights for the IXORA-R H2H trial.
- Investopedia•15 days ago
Top 3 Healthcare ETFs for 2018
The solid performance of the healthcare market in the first eight months of 2018 has created investment opportunities. These ETFs are poised to take advantage.
- Benzinga•17 days ago
Health Care Has Been On Fire. Will The Uptrend Continue?
Health care has been the hottest sector of the US equities market over the last three months. According to Thomson Reuters Lipper Alpha, 94 percent of health care companies exceeded earnings expectations for the second quarter. A Goldman Sachs analysis concluded that hedge funds have more than 17 percent of their assets invested in health care, making it the largest weighting of any sector.
Market Realist•18 days agoUnitedHealth Group Stock at 52-Week High, Up 22% Year-to-Date
On September 5, UnitedHealth Group (UNH) ended the trading day at $267.64. The stock was marginally down from its previous day’s closing price. However, the stock registered its 52-week high of $270.17 last week on August 30. It was trading at its 52-week low of $186 on October 13, 2017.
